BIIB - Biogen Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue13,452,90012,273,90011,448,80010,763,800
Cost of Revenue1,816,3001,630,0001,433,2001,240,400
Gross Profit11,636,60010,643,90010,015,6009,523,400
Operating Expenses
Research Development2,597,2002,253,6001,973,3002,012,800
Selling General and Administrative2,098,2001,917,9001,949,9002,113,100
Non Recurring----
Others185,000112,30010,20010,200
Total Operating Expenses7,077,9006,369,1005,740,0005,748,900
Operating Income or Loss6,375,0005,904,8005,708,8005,014,900
Income from Continuing Operations
Total Other Income/Expenses Net-475,400-776,000-775,800-260,100
Earnings Before Interest and Taxes6,375,0005,904,8005,708,8005,014,900
Interest Expense-200,600-250,800-260,000-95,500
Income Before Tax5,899,6005,128,8004,933,0004,754,800
Income Tax Expense1,425,6002,458,7001,237,3001,161,600
Minority Interest-8,000-14,700-11,5002,100
Net Income From Continuing Ops4,474,0002,670,1003,695,7003,593,200
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income4,430,7002,539,1003,702,8003,547,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares4,430,7002,539,1003,702,8003,547,000